# OnCo record paper-horwitz-lancet (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-horwitz-lancet/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-horwitz-lancet" ;
  schema:name "Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial"@en ;
  schema:description "Paper cited by one cancer page, indexed on Europe PMC as PubMed record 30522922 and published in The Lancet; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-horwitz-lancet/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s0140-6736(18)32984-2>, <https://pubmed.ncbi.nlm.nih.gov/30522922/>, <https://europepmc.org/article/MED/30522922> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s0140-6736(18)32984-2> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Horwitz S, O'Connor OA, Pro B, et al." ;
  onco:related <https://onco.cc/cancers/peripheral-t-cell-lymphoma/> ;
  onco:journals <https://onco.cc/journals/lancet/> .